About BetaGlue Technologies
BetaGlue Technologies is a company based in Milano (Italy) founded in 2017.. BetaGlue Technologies has raised $18.91 million across 2 funding rounds from investors including Profectus Capital, European Commission and Liftt. BetaGlue Technologies offers products and services including YntraDose. BetaGlue Technologies operates in a competitive market with competitors including EMulate Therapeutics, CNRT, RITA Medical Systems, Phosphorex and Trod Medical, among others.
- Headquarter Milano, Italy
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Betaglue Therapeutics Spa
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$18.91 M (USD)
in 2 rounds
-
Latest Funding Round
$8.71 M (USD), Series A
Jun 07, 2024
-
Investors
Profectus Capital
& 8 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of BetaGlue Technologies
BetaGlue Technologies offers a comprehensive portfolio of products and services, including YntraDose. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Platform for targeted and personalized treatment of solid tumours.
Unlock access to complete
Unlock access to complete
Funding Insights of BetaGlue Technologies
BetaGlue Technologies has successfully raised a total of $18.91M across 2 strategic funding rounds. The most recent funding activity was a Series A round of $8.71 million completed in June 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 2
- Last Round Series A — $8.7M
-
First Round
First Round
(20 Jul 2022)
- Investors Count 9
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun, 2024 | Amount | Series A - BetaGlue Technologies | Valuation | Neva SGR , LIFTT | |
| Jul, 2022 | Amount | Series A - BetaGlue Technologies | Valuation | Fin Posillipo , Kairos |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in BetaGlue Technologies
BetaGlue Technologies has secured backing from 9 investors, including institutional and venture fund investors. Prominent investors backing the company include Profectus Capital, European Commission and Liftt. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital firm focused on multiple sectors
|
Founded Year | Domain | Location | |
|
Neva SGR is engaged in venture capital investments globally.
|
Founded Year | Domain | Location | |
|
VC firm investing in seed and early stage companies in Italy
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by BetaGlue Technologies
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - BetaGlue Technologies
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Betaglue Technologies Comparisons
Competitors of BetaGlue Technologies
BetaGlue Technologies operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as EMulate Therapeutics, CNRT, RITA Medical Systems, Phosphorex and Trod Medical, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Radiofrequency devices for cancer treatment are developed using ultra-low energy.
|
|
| domain | founded_year | HQ Location |
Medical isotopes are supplied for tumor diagnosis and treatment.
|
|
| domain | founded_year | HQ Location |
Oncology therapy products, including ablation and embolization systems, are developed.
|
|
| domain | founded_year | HQ Location |
Polymeric nanospheres, microspheres, and drug delivery solutions are developed.
|
|
| domain | founded_year | HQ Location |
Develops innovative RF-based focal ablation devices for tumor treatment.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Betaglue Technologies
Frequently Asked Questions about BetaGlue Technologies
When was BetaGlue Technologies founded?
BetaGlue Technologies was founded in 2017 and raised its 1st funding round 5 years after it was founded.
Where is BetaGlue Technologies located?
BetaGlue Technologies is headquartered in Milano, Italy.
Who is the current CEO of BetaGlue Technologies?
Antonino Amato is the current CEO of BetaGlue Technologies.
Is BetaGlue Technologies a funded company?
BetaGlue Technologies is a funded company, having raised a total of $18.91M across 2 funding rounds to date. The company's 1st funding round was a Series A of $10.21M, raised on Jul 20, 2022.
What does BetaGlue Technologies do?
BetaGlue Technologies was founded in 2017 in Milano, Italy, within the medical devices sector. A proprietary platform is developed, combining radioactive glue, β-emitting radiotherapy, and external beam radiation therapy. This system targets patients with solid tumors and various cancers. A drug delivery mechanism is also included in the operations, focusing on oncology treatments.
Who are the top competitors of BetaGlue Technologies?
BetaGlue Technologies's top competitors include EMulate Therapeutics, Phosphorex and CNRT.
What products or services does BetaGlue Technologies offer?
BetaGlue Technologies offers YntraDose.
Who are BetaGlue Technologies's investors?
BetaGlue Technologies has 9 investors. Key investors include Profectus Capital, European Commission, Liftt, Kairos Partners, and Fin Posillipo.